J C Oliver

866 total citations
16 papers, 464 citations indexed

About

J C Oliver is a scholar working on Nephrology, Immunology and Molecular Biology. According to data from OpenAlex, J C Oliver has authored 16 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Nephrology, 4 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in J C Oliver's work include Dialysis and Renal Disease Management (6 papers), Central Venous Catheters and Hemodialysis (2 papers) and Immune Response and Inflammation (2 papers). J C Oliver is often cited by papers focused on Dialysis and Renal Disease Management (6 papers), Central Venous Catheters and Hemodialysis (2 papers) and Immune Response and Inflammation (2 papers). J C Oliver collaborates with scholars based in United States and Spain. J C Oliver's co-authors include Carl W. Oettinger, Matthew J. Arduino, Sigrid K. McAllister, L A Bland, Gere S. diZerega, Kathleen E. Rodgers, Martin S. Favero, S M Aguero, Steven M. Gordon and William R. Jarvis and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American Society of Nephrology and Annals of Oncology.

In The Last Decade

J C Oliver

16 papers receiving 445 citations

Peers

Countries citing papers authored by J C Oliver

Since Specialization

Citations

This map shows the geographic impact of J C Oliver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J C Oliver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J C Oliver more than expected).

Fields of papers citing papers by J C Oliver

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J C Oliver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J C Oliver. The network helps show where J C Oliver may publish in the future.

Co-authorship network of co-authors of J C Oliver

This figure shows the co-authorship network connecting the top 25 collaborators of J C Oliver. A scholar is included among the top collaborators of J C Oliver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J C Oliver. J C Oliver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Phase 1 open-label trial to evaluate the safety and immunogenicity of PAN-301-1, a novel nanoparticle therapeutic vaccine, in patients with biochemically relapsed prostate cancer. 2018 ·Journal of Clinical Oncology ·Luke T. Nordquist, Neal D. Shore, (unknown), J C Oliver, William E. Gannon, Amir H. Shahlaee, Steven A. Fuller, Hossein Ghanbari	5
2	Final results from a phase i clinical trial evaluating the safety, immunogenicity, and anti-tumor activity of SNS-301 in men with biochemically relapsed prostate cancer 2018 ·Annals of Oncology ·Luke T. Nordquist, Hossein Ghanbari, (unknown), J C Oliver, William E. Gannon, Amir H. Shahlaee, Steve Fuller, Neal D. Shore	2
3	A dose-finding pharmacokinetic study of IT-101, the first de novo designed nanoparticle therapeutic, in refractory solid tumors 2008 ·Journal of Clinical Oncology ·J C Oliver, Yi‐Hao Yen, Timothy W. Synold, Thomas Schluep, Mark M. Davis	10
4	Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancer 2005 ·Cancer Chemotherapy and Pharmacology ·Kathleen E. Rodgers, J C Oliver, Gere S. diZerega	83
5	Delayed graft function after renal transplantation in patients undergoing peritoneal dialysis and hemodialysis. 1996 ·PubMed ·Miguel Pérez Fontán, Ana Rodríguez–Carmona, (unknown), Teresa García Falcón, Magdalena Adeva, Francisco Valdés, J C Oliver	21
6	Potency of endotoxin from bicarbonate dialysate compared with endotoxins from Escherichia coli and Shigella flexneri. 1995 ·Journal of the American Society of Nephrology ·L A Bland, J C Oliver, Matthew J. Arduino, Carl W. Oettinger, Sigrid K. McAllister, (unknown)	12
7	The Clinical Relevance of Dialysate Sterility 1994 ·Seminars in Dialysis ·Carl W. Oettinger, Matthew J. Arduino, J C Oliver, Lee A. Bland	6
8	The effect of uremia on tumor necrosis factor-alpha release after an in vitro whole-blood endotoxin challenge. 1994 ·Journal of the American Society of Nephrology ·Carl W. Oettinger, L A Bland, J C Oliver, Matthew J. Arduino, Sigrid K. McAllister, (unknown)	18
9	Normalization of uremic acidosis in hemodialysis patients with a high bicarbonate dialysate. 1993 ·Journal of the American Society of Nephrology ·Carl W. Oettinger, J C Oliver	53
10	Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge. 1993 ·PubMed ·J C Oliver, L A Bland, Carl W. Oettinger, Matthew J. Arduino, Sigrid K. McAllister, S M Aguero, Martin S. Favero	117
11	The effects of calcium carbonate as the sole phosphate binder in combination with low calcium dialysate and calcitriol therapy in chronic hemodialysis patients. 1992 ·Journal of the American Society of Nephrology ·Carl W. Oettinger, J C Oliver, Edwin J. Macon	12
12	Bacteria and Endotoxin Removal from Bicarbonate Dialysis Fluids for Use in Conventional, High‐Efficiency, and High‐Flux Hemodialysis 1992 ·Artificial Organs ·J C Oliver, Lee A. Bland, Carl W. Oettinger, Matthew J. Arduino, (unknown), David A. Pegues, Sigrid K. McAllister, (unknown), Sonia M. Aguero, Martin S. Favero	14
13	A prospective study of pyrogenic reactions in hemodialysis patients using bicarbonate dialysis fluids filtered to remove bacteria and endotoxin. 1992 ·Journal of the American Society of Nephrology ·David A. Pegues, Carl W. Oettinger, L A Bland, J C Oliver, Matthew J. Arduino, S M Aguero, Sigrid K. McAllister, Steven M. Gordon, Martin S. Favero, William R. Jarvis	39
14	Pyrogenic reactions in patients receiving conventional, high-efficiency, or high-flux hemodialysis treatments with bicarbonate dialysate containing high concentrations of bacteria and endotoxin. 1992 ·Journal of the American Society of Nephrology ·Steven M. Gordon, Carl W. Oettinger, L A Bland, J C Oliver, Matthew J. Arduino, S M Aguero, Sigrid K. McAllister, Martin S. Favero, William R. Jarvis	39
15	Lack of plasma interleukin-1 beta or tumor necrosis factor-alpha elevation during unfavorable hemodialysis conditions. 1991 ·Journal of the American Society of Nephrology ·Anne C. Powell, (unknown), Carl W. Oettinger, Sigrid K. McAllister, J C Oliver, Matthew J. Arduino, (unknown)	28
16	An Economical New Process for Incenter Bicarbonate Dialysate Production: Comparison with Acetate in a Large Dialysis Population 1989 ·Artificial Organs ·Carl W. Oettinger, J C Oliver	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact